RRM1 and gastric cancer: RRM1 also significantly predicted a poor prognosis in two independent GC populations (COH and ZJU sets) with different racial and socio-economic backgrounds (Fig. 3), suggesting that RRM1 might serve as a potential biomarker for predicting poor survival in GC patients.